Loading...
Dernières publications
-
Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, et al.. Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants. BMC Infectious Diseases, 2024, 24 (1), pp.1049. ⟨10.1186/s12879-024-09861-5⟩. ⟨hal-04724620⟩
-
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, et al.. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩. ⟨hal-04596145⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
88
Notices
64
Mots clés
Influenza
Vaccine acceptance
Chemotherapy
Incidence
Attitude
Vaccine hesitancy
HIV
Determinants
Vaccine
Assay
COCONEL cohort surveys
Conjugate pneumococcal vaccine
COVID-19
Immunocompromised
COVID-19 vaccines
Vaccine effectiveness
Delphi study
Clinical skills
Antiviral agents
B-lymphocytes
Adenoviral vector
Covid 19
ANTIRETROVIRAL THERAPY
Adjuvant
Internet
HPV vaccine
Data sharing
Cohort study
Attitude to health
DMD
Hesitancy
Cystic fibrosis
Adults
CERVICOVAGINAL SECRETIONS
Catch-up
Clinical practice
Covidom
Clinical research
Hospitalisations
Virology
Determinant
Immunization
Vaccines
AstraZeneca vaccine
Antiviral therapy
AIDS
Co-morbidities
Deletion
Coronavirus
Cohort
Innate immunity
Care management
C-type lectin receptor
Sleep
SARS-CoV-2
Specific populations
Attitudes of health personnel
Effectiveness
Antiretroviral therapy
Bayes' theorem
Older adults
Diabetes mellitus type 2
Elderly
Influenza-like illness
Practices
Calcium phosphorus evaluation
Confidence
Cancer
Chronic kidney disease
Healthcare workers
Coadministration
Covid-19
Clinical trials
Acute kidney injury
Immunogenicity
Alpha variant
Adverse effects
1790GAHB F
COVID-19 mRNA vaccine
Vaccine safety and efficacy
AON
Digital care
Breakthrough infections
Respiratory syncytial virus
Attitudes
Risk factors
Booster response
Biomarkers
Dialysis
Cost of illness
Efficacy
Epidemiology
Vaccination
Misinformation
Dendritic cells
Boys
Awareness
France
Conditional marketing authorization
Antiviral